Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Sho Nakai"'
Autor:
Yoshiki Yamada, Toru Wakamatsu, Yoshinori Imura, Hironari Tamiya, Toshinari Yagi, Rie Suzuki, Akitomo Inoue, Haruna Takami, Sho Nakai, Hidetatsu Outani, Shigeki Kakunaga, Satoshi Takenaka
Publikováno v:
World Journal of Surgical Oncology, Vol 22, Iss 1, Pp 1-9 (2024)
Abstract Background Retroperitoneal dedifferentiated liposarcoma is associated with a high risk of recurrence; however, treatment strategies that are more effective than surgery remain to be established. This study aimed to determine the optimal numb
Externí odkaz:
https://doaj.org/article/0a955f8f9864433192680ee137a69043
Autor:
Rie Suzuki, Toru Wakamatsu, Keiichi Yoshida, Yukiko Matsuoka, Haruna Takami, Sho Nakai, Hironari Tamiya, Shigeki Kakunaga, Toshinari Yagi, Ken-ichi Yoshida, Yoshinori Imura, Yoshihiro Yui, Satoru Sasagawa, Satoshi Takenaka
Publikováno v:
Journal of Bone Oncology, Vol 41, Iss , Pp 100486- (2023)
Malignant giant-cell tumors are extremely rare bone sarcomas that transform from conventional giant-cell tumors during long periods of treatment. Owing to their rarity, no further analysis of their molecular pathogenesis exists, and thus, no standard
Externí odkaz:
https://doaj.org/article/d903d42800474939a0e99b5c544631b2
Autor:
Yoshinori Imura, Satoshi Takenaka, Hidetatsu Outani, Takaaki Nakai, Naohiro Yasuda, Sho Nakai, Toru Wakamatsu, Hironari Tamiya, Seiji Okada
Publikováno v:
Current Oncology, Vol 29, Iss 4, Pp 2301-2311 (2022)
Background: Few studies have described the characteristics and prognostic factors of patients with metastatic extrauterine leiomyosarcoma (euLMS). Therefore, we retrospectively investigated the clinicopathological features, clinical outcomes, and pro
Externí odkaz:
https://doaj.org/article/84022c8882074a419af8d27849752875
Autor:
Toru Wakamatsu, Hisataka Ogawa, Keiichi Yoshida, Yukiko Matsuoka, Kazuko Shizuma, Yoshinori Imura, Hironari Tamiya, Sho Nakai, Toshinari Yagi, Shigenori Nagata, Yoshihiro Yui, Satoru Sasagawa, Satoshi Takenaka
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundAlthough biological resources are essential for basic and preclinical research in the oncological field, those of sarcoma are not sufficient for rapid development of the treatment. So far, some sarcoma cell lines have been established, howe
Externí odkaz:
https://doaj.org/article/fdc11287233f4f07a63bb929516e72f9
Autor:
Naohiro Yasuda, Satoshi Takenaka, Sho Nakai, Takaaki Nakai, Shutaro Yamada, Yoshinori Imura, Hidetatsu Outani, Kenichiro Hamada, Hideki Yoshikawa, Norifumi Naka
Publikováno v:
FEBS Open Bio, Vol 10, Iss 5, Pp 767-779 (2020)
Osteosarcoma is the most common malignant bone tumor in adolescence and childhood. Metastatic osteosarcoma has a poor prognosis with an overall 5‐year survival rate of approximately 20%. TAS‐115 is a novel multiple receptor tyrosine kinase inhibi
Externí odkaz:
https://doaj.org/article/5cbf079bfe7f41048f35778ed30cb849
Autor:
Hidetatsu Outani, Shigeki Kakunaga, Kenichiro Hamada, Satoshi Takenaka, Sho Nakai, Naohiro Yasuda, Yoshinori Imura, Norifumi Naka, Nobuhito Araki, Takafumi Ueda, Hideki Yoshikawa
Publikováno v:
World Journal of Surgical Oncology, Vol 18, Iss 1, Pp 1-6 (2020)
Abstract Background Chondroblastoma (CB) is a rare locally aggressive bone tumor that commonly occurs in the epiphysis or apophysis of long bones. Although surgical treatment of CB carries potential risk for physeal or articular cartilage damage, ris
Externí odkaz:
https://doaj.org/article/b379fef1c96a4b5ca9bb7640bc51a625
Autor:
Yoshinori Imura, Hidetatsu Outani, Satoshi Takenaka, Naohiro Yasuda, Sho Nakai, Takaaki Nakai, Toru Wakamatsu, Hironari Tamiya, Kenichiro Hamada, Shigeki Kakunaga
Publikováno v:
Sarcoma, Vol 2021 (2021)
Introduction. Few studies have described the characteristics and prognostic factors of patients with malignant peripheral nerve sheath tumour (MPNST). In this study, we retrospectively investigated the clinicopathological features, clinical outcomes,
Externí odkaz:
https://doaj.org/article/824f314714f848e480489e787031bb73
Autor:
Shutaro Yamada, Yoshinori Imura, Takaaki Nakai, Sho Nakai, Naohiro Yasuda, Keiko Kaneko, Hidetatsu Outani, Satoshi Takenaka, Kenichiro Hamada, Akira Myoui, Nobuhito Araki, Takafumi Ueda, Kazuyuki Itoh, Hideki Yoshikawa, Norifumi Naka
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-14 (2017)
Abstract Background The prognosis of synovial sarcoma (SS), an aggressive soft tissue sarcoma, remains poor. We previously reported that c-MET or platelet-derived growth factor receptor α (PDGFRα) signalling pathway is related to SS progression bas
Externí odkaz:
https://doaj.org/article/0a9f7289c3704ad280f60fd471aef4c1
SHARPIN Enhances Ferroptosis in Synovial Sarcoma Cells via NF-κB- and PRMT5-Mediated PGC1α Reduction
Autor:
Kakunaga, Hironari Tamiya, Naoko Urushihara, Kazuko Shizuma, Hisataka Ogawa, Sho Nakai, Toru Wakamatsu, Satoshi Takenaka, Shigeki
Publikováno v:
Cancers; Volume 15; Issue 13; Pages: 3484
Sarcoma is a rare type of cancer for which new therapeutic agents are required. Ferroptosis is a nonapoptotic cell death triggered by iron-mediated lipid peroxidation. We found that TFRC, an iron uptake protein, was expressed at higher levels in sarc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::ef90266f0b9ce0fde63fb758ee3b78d4
Publikováno v:
Genes, Chromosomes and Cancer. 62:184-186
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c7acaf79905cb7afc17864740d8866c
https://doi.org/10.1002/gcc.23113
https://doi.org/10.1002/gcc.23113